Antidepressant use in dementia: Assessing effective strategies for a vulnerable population

IF 7.9 1区 医学 Q1 BEHAVIORAL SCIENCES
Mariagiovanna Cozza , Filippo Luca Fimognari , Alberto Castagna , Virginia Boccardi
{"title":"Antidepressant use in dementia: Assessing effective strategies for a vulnerable population","authors":"Mariagiovanna Cozza ,&nbsp;Filippo Luca Fimognari ,&nbsp;Alberto Castagna ,&nbsp;Virginia Boccardi","doi":"10.1016/j.neubiorev.2025.106340","DOIUrl":null,"url":null,"abstract":"<div><div>Depression is closely associated with dementia and may serve as a risk factor, an early symptom, or a prodromal feature, particularly in Alzheimer’s disease, the most common form of dementia. It can also emerge during disease progression, not only in Alzheimer's but in other dementias such as vascular dementia, Lewy body dementia, and frontotemporal dementia. Recognizing the timing and context of depressive symptoms is crucial for accurate diagnosis and management. While non-pharmacological interventions and psychosocial approaches are generally recommended as the first line of treatment, clinical practice often sees widespread use of antidepressants in this vulnerable population. However, such usage is not always supported by robust evidence, particularly given the heightened risk of side effects in older adults with cognitive decline. This narrative review seeks to critically examine the role of antidepressants in managing depression among patients with dementia. Rather than dismissing their use outright, we aim to provide a novel perspective on their application, emphasizing the importance of a thorough multidimensional geriatric assessment. The attempt is to help the clinicians in making more individualized, evidence-based decisions that balance the potential benefits and risks, ensuring that treatment is tailored to the unique needs of each patient.</div></div>","PeriodicalId":56105,"journal":{"name":"Neuroscience and Biobehavioral Reviews","volume":"177 ","pages":"Article 106340"},"PeriodicalIF":7.9000,"publicationDate":"2025-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuroscience and Biobehavioral Reviews","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0149763425003410","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BEHAVIORAL SCIENCES","Score":null,"Total":0}
引用次数: 0

Abstract

Depression is closely associated with dementia and may serve as a risk factor, an early symptom, or a prodromal feature, particularly in Alzheimer’s disease, the most common form of dementia. It can also emerge during disease progression, not only in Alzheimer's but in other dementias such as vascular dementia, Lewy body dementia, and frontotemporal dementia. Recognizing the timing and context of depressive symptoms is crucial for accurate diagnosis and management. While non-pharmacological interventions and psychosocial approaches are generally recommended as the first line of treatment, clinical practice often sees widespread use of antidepressants in this vulnerable population. However, such usage is not always supported by robust evidence, particularly given the heightened risk of side effects in older adults with cognitive decline. This narrative review seeks to critically examine the role of antidepressants in managing depression among patients with dementia. Rather than dismissing their use outright, we aim to provide a novel perspective on their application, emphasizing the importance of a thorough multidimensional geriatric assessment. The attempt is to help the clinicians in making more individualized, evidence-based decisions that balance the potential benefits and risks, ensuring that treatment is tailored to the unique needs of each patient.
抗抑郁药在痴呆中的使用:评估弱势群体的有效策略
抑郁症与痴呆症密切相关,可能是一种风险因素、早期症状或前驱特征,尤其是在阿尔茨海默病(最常见的痴呆症形式)中。它也可以在疾病进展中出现,不仅在阿尔茨海默氏症中,而且在其他痴呆症中,如血管性痴呆、路易体痴呆和额颞叶痴呆。认识到抑郁症状的时间和背景对准确诊断和管理至关重要。虽然非药物干预和社会心理方法通常被推荐作为一线治疗,但临床实践经常看到在这一弱势群体中广泛使用抗抑郁药。然而,这种用法并不总是得到有力证据的支持,特别是考虑到对认知能力下降的老年人产生副作用的风险增加。这篇叙述性综述旨在批判性地研究抗抑郁药在痴呆患者抑郁管理中的作用。而不是直接驳回他们的使用,我们的目标是提供一个新的视角,他们的应用,强调一个全面的多维老年评估的重要性。其目的是帮助临床医生做出更个性化的、基于证据的决定,平衡潜在的利益和风险,确保治疗适合每个病人的独特需求。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
14.20
自引率
3.70%
发文量
466
审稿时长
6 months
期刊介绍: The official journal of the International Behavioral Neuroscience Society publishes original and significant review articles that explore the intersection between neuroscience and the study of psychological processes and behavior. The journal also welcomes articles that primarily focus on psychological processes and behavior, as long as they have relevance to one or more areas of neuroscience.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信